Resistance to antibiotics is a looming systemic risk for investors, but too few have the bandwidth or awareness to take it on.
The post Antibiotics: Investors’ Blindspot first appeared on Interfaith Center on Corporate Responsibility.
Resistance to antibiotics is a looming systemic risk for investors, but too few have the bandwidth or awareness to take it on.
The post Antibiotics: Investors’ Blindspot first appeared on Interfaith Center on Corporate Responsibility.